2011 Accounts
Financial accounts
Balance sheet as of December 31, 2011
2011 (EUR) | 2010 (EUR) |
|
ASSETS | ||
Current assets | ||
Debtors EU Commission | 69 704 | 100 000 |
Other debtors | 4 599 | 26 843 |
Cash at bank and on deposit | 519 119 | 527 841 |
593 422 | 654 684 |
|
Prepayments | 22 819 | 4 826 |
TOTAL ASSETS | 616 241 | 659 510 |
LIABILITIES | ||
Capital and reserves | ||
Results brought forward | 169 200 | 162 675 |
Result of the year | 4 726 | 6 525 |
173 926 | 169 200 |
|
Creditors | ||
Payments received on account | 143 438 | 86 433 |
Trade creditors | 67 268 | 55 743 |
Other liabilities | 41 273 | 45 582 |
251 979 | 187 758 |
|
Deferred income | 190 336 | 302 552 |
TOTAL LIABILITIES | 616 241 | 659 510 |
Profit and loss account year ended December 31, 2011
2011 (EUR) | (2010 (EUR) |
|
Other operating income | ||
Corporate sponsorship | 388 533 | 559 540 |
Deferred income | 302 552 | 22 919 |
Sponsorship received on account | -190 336 | -302 552 |
EU Subsidy | 226 698 | 250 000 |
Co-financing in kind | 144 287 | 138 680 |
Membership fees and countributions | 66 087 | 53 150 |
Donations | 767 | 263 |
Publication sales and royalties | 1 303 | 12 240 |
Project participation and other subsidies | 19 000 | 59 320 |
Other operating income | 10 041 | 23 973 |
AE Conference registration fees | 79 644 | 65 700 |
Unpayable debts | 4 |
|
External charges | ||
External experts | -424 747 | -340 578 |
Publication and information material | -114 968 | -91 626 |
Travel expenses | -57 041 | -47 598 |
Communication costs | -21 281 | -20 688 |
Accommodation expenses | -114 185 | -127 997 |
Office rent and associated costs | -24 481 | -25 011 |
Office stationary and related costs | -2 761 | -2 366 |
Leasing | -32 517 | -13 069 |
Membership fees | -1 120 | -1 120 |
Other costs | -2 608 | -2 282 |
Irrecoverable EU subsidy | -13 621 | |
Staff costs | ||
Wages and salaries | -204 992 | -182 859 |
Social security costs | -24 606 | -22 544 |
Interest receivable and similar income | 1 840 | 3 081 |
Interest payable and similar charges | -6 762 | -2 055 |
4 726 | 6 525 |
|
Introduction
In 2011, Alzheimer Europe had an audited income of EUR 1.240,751.74 of which EUR 715,693.85 (57.68%) were for the organisation’s core activities (including the organisation’s Dementia Ethics Network and Annual Conference), EUR 207,012.08 (16.681%) were for the organisation’s public affairs activities and EUR 318,045.81 (25.63%) for the organisation’s “Value of diagnosis” project.
Funding of core activities (EUR 715,693.85)
In 2011, the core funding of Alzheimer Europe was composed as follows:
- EUR 226,697.71 (31.68%) from public funding,
- EUR 196,874.09 (27.51%) from member organisations,
- EUR 110,406.35 (15.43%) from deferred income brought forward from the financial year 2010,
- EUR 81,714.30 (11.42%) from individuals,
- EUR 60,500 (8.45%) from corporate sources,
- EUR 28,600 (4.00%) from foundations and other non-profit organisations,
- EUR 9,061.13 (1.27%) from other sources and
- EUR 1,840.27 (0.26%) from bank interest and similar.
Public funding
In 2011, the breakdown of public funding totalling EUR 226,697.71 can be broken down as follows:
- Alzheimer Europe received EUR 189,703.52 as an operating grant from the European Commission, EUR 19,940.63 for its participation in the PharmaCog project and EUR 17,053.56 for its participation in the DECIDE project.
Funding from member organisations
In 2010, the EUR 196,874.09 funding from member organisations can be broken down as follows:
- EUR 87,587.49 from the Luxembourg member organisation through the secondment of the AE Executive Director,
- EUR 53,850 in membership fees,
- EUR 12,000 from the Luxembourg member organisation by providing the offices of Alzheimer Europe free of rent,
- EUR 12,236.60 from member organisations covering the travel expenses of AE Board members to attend Board meetings,
- EUR 31,200 in co-financing from Board members and representatives of member organisations in time donated to the organisation (at EUR 300 per day).
Deferred income
In 2011, Alzheimer Europe was able to contribute EUR 110,406.35 to its core activities which came from deferred income in 2010.
Individuals
In 2011, AE received EUR 81,714.30 from individuals which can be broken down as follows:
- EUR 79,643.99 in conference registrations,
- EUR 1,303.38 in publication sales and
- EUR 766.93 in donations.
Corporate support
In 2011, Alzheimer Europe received EUR 60,500 from corporate sources as core-funding which can be broken down as follows:
- EUR 15,000 from Bayer, EUR 10,000 from Janssen, Lilly and Pfizer, EUR 7,500 from Sanofi-Aventis and EUR 5,000 from SCA Global Hygiene as support to the Alzheimer Europe Conference in Warsaw,
- EUR 3,000 from Mazars which carried out the audit of the organisation’s accounts free of charge and
Foundations and organisations
The EUR 28,600 which Alzheimer Europe received in 2011 from foundations and other non-profit organisations can be broken down as follows:
- EUR 5,000 from Fondation Médéric Alzheimer and Fondation Roi Baudouin to support the Alzheimer Europe Conference in Warsaw,
- EUR 9,000 from Fondation Médéric Alzheimer to support the legal rights activities of Alzheimer Europe,
- EUR 9,600 in donated time by experts involved in the ethical work of Alzheimer Europe (at EUR 300 per day)..
Bank interest and similar
In 2011, Alzheimer Europe had an income of EUR 1,804.27 from bank interest and similar income.
Other income
In 2011, EUR 9,061.13 came from other sources not mentioned above.
Funding of public affairs activities (EUR 207,012.08)
In 2011, Alzheimer Europe received EUR 207,012.08 for its public affairs activities, of which
- EUR 206,032.60 (99.53%) came from corporate sponsors and
- EUR 979.48 (0.47%) from other income.
Corporate support
The corporate support received by Alzheimer Europe for its public affairs activities in 2011 (EUR 206,032.90) can be broken down as follows:
- Pfizer, Janssen and Lilly each contributed EUR 40,000 as a gold sponsor,
- GlaxoSmithKline contributed EUR 35,000 in support,
- Lundbeck and Sanofi contributed EUR 20,000 each as silver sponsors and
- SCA Global Hygiene contributed EUR 10,000 as a bronze sponsor.
In addition, AE received EUR 108.80 in travel support from Pfizer and EUR 923.80 as travel support and honoraria from GlaxoSmithKline.
Other income
In 2011, EUR 979.48 came from sources not included above.
Funding of Value of Knowing-project (EUR 318,045.81)
In 2011, the funding of the Value of Knowing project was composed as follows:
- EUR 125.000 (39.30%) from corporate funding,
- EUR 192,145.81 (60.41%) from reserves brought forward from the financial year 2010 and
- EUR 900 (0.28%) from member organisations.
Corporate support
In 2011, AE received an educational grant of EUR 125,000 from Bayer Healthcare for its Value of Knowing project.
Deferred income
In 2011, Alzheimer Europe contributed EUR 192,145.81 to the Value of knowing project from income received on account in 2010.
Foundations and organisations
EUR 900 of the income of the Value of Knowing project consisted in time donated by Board members to the project (at EUR 300 per day).
Overall funding
The following table lists all sources of income received in 2011.
In line with the policy of the European Medicines Agency on transparency requirements for accredited patients’ organisations, this is presented in total amounts as well as in terms of percentages of the overall income of the organisation.
Funding source | Funding received (2011) | As % of AE income (2011) |
Bayer | 140,000.00 | 11.28% |
Pfizer | 50,108.80 | 4.04% |
Janssen | 50,000.00 | 4.03% |
Lilly | 50,000.00 | 4.03% |
GlaxoSmithKline | 35,923.80 | 2.90% |
Sanofi | 27,500.00 | 2.22% |
Lundbeck | 20,000.00 | 1.61% |
Sub-total: Pharmaceutical funding | 373,532.60 | 30.11% |
SCA Global Hygiene | 15,000.00 | 1.21% |
Mazars | 3,000.00 | 0.24% |
Sub-total: Other corporate sources | 18,000.00 | 1.45% |
Total: Corporate funding | 391,532.60 | 31.56% |
Deferred incomes | 302,552.16 | 24.38% |
Total: Deferred income | 302,552.16 | 24.38% |
European Commission | 226,697.71 | 18.27% |
Total: Public funding | 226,697.71 | 18.27% |
Association Luxembourg Alzheimer | 99,587.49 | 8.03% |
Other member organisations | 98,186.60 | 7.91% |
Total: Member organisations | 197,774.09 | 15.94% |
Individuals (Conference fees, donations, registration fees) | 81,714.30 | 6.59% |
Total: Individuals | 81,714.30 | 6.59% |
Fondation Médéric Alzheimer | 14,000.00 | 1.13% |
Fondation Roi Baudouin | 5,000.00 | 0.40% |
Other organisations | 9,600.00 | 0.77 |
Total: Foundations and organisations | 28,600 | 2.31% |
Bank interest and similar | 1,840.27 | 0.15% |
Total: Bank interest and similar | 1,840.27 | 0.15% |
Other income | 10,040.61 | 0.81% |
Total: Other income | 10,040.61 | 0.81% |
Total Income | 1,240,751.74 | 100.00% |
Last Updated: Monday 12 November 2012